Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03778515 · ClinicalTrials.gov registry record
Novel Quantitative MRI for Axial Spondyloarthritis
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03778515 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 1 participants.
The verdict
NCT03778515 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This proposal aims to develop novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in patients with Ankylosing Spondylitis (AS). The quantitative evaluation will be more objective and reproducible, more sensitive to subtle changes, and less time consuming, as compared to the current semi-quantitative evaluation. It will allow radiologists and rheumatologists to evaluate the inflammation and structural changes more reliably to improve early diagnosis and treatment response evaluation. The developed quantification tools can be disseminated to other research and clinical sites for retrospective and prospective data analysis, and used as outcome measures for future multi-center trials. The evaluation of vascularity will enhance Investigators understanding of disease pathophysiology and serve as a novel marker to improve investigators capability of evaluating and predicting treatment response in AS. The successful implementation will greatly assist clinicians to optimize individualized therapeutic strategies and ultimately improve patient care for AS.
Interventions
- DIAGNOSTIC_TEST MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03778515
The ClinicalTrials.gov registry entry for NCT03778515 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT03778515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03778515 about?
NCT03778515 is a clinical study titled "Novel Quantitative MRI for Axial Spondyloarthritis". This proposal aims to develop novel MR imaging and image processing techniques that will provide reliable and fully quantitative evaluation of inflammation, chronic structural changes and vascularity in patients with Ankylosing Spondylitis (AS). The quantitative evaluation will be more objective and...
What is the current status of trial NCT03778515?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2020-01-15. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03778515?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03778515?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.